By Mackenzie Tatananni, George Glover, Joe Woelfel, and Connor Smith
Stocks ticked lower Friday as the market absorbed President Donald Trump's latest comments on geopolitical tensions and the Federal Reserve.
These stocks made moves:
Micron Technology jumped 7.8%. Board member Mark Liu snapped up $7.8 million worth of shares, according to a securities filing. Purchases by corporate insiders tend to signal conviction in a company's growth story -- and that's particularly notable given how well Micron has performed lately. The stock has risen 237% in 12 months, thanks to stellar earnings that reflected sky-high demand for flash memory chips.
Memory-chip maker Sandisk traded rose 1.1%. Shares closed up 5.5% on Thursday after two analysts hiked their price targets.
Hard-drive maker Western Digital, which spun off Sandisk in February 2025, fell 0.3%, while peer Seagate Technology added 1.9%.
GE Vernova advanced 6.1%. The Trump administration is pushing PJM, the nation's largest electricity grid operator, to hold a special auction to supply data centers. Trump on Friday signed an agreement with several governors from states in the mid-Atlantic region to encourage the construction of power plants.
Shares in Constellation Energy and Vistra, the owners of existing plants, sank 9.8% and 7,5%, respectively.
AST SpaceMobile soared 14%, extending gains from the previous session when it advanced 6.3%. The satellite-communications company was selected as one of the eligible vendors to the U.S. Missile Defence Agency, in the latest tranche of awards for its SHIELD program.
Mosaic tumbled 4.5%. In an earnings pre-announcement, the chemical company said fourth-quarter fertilizer demand had fallen well beyond normal seasonal softness. Mosaic expects phosphate sales volumes of 1.3 million tons and potash sales volumes of 2.2 million tons.
U.S.-listed shares of Novo Nordisk climbed 9.1%. The drugmaker secured approval for a higher dose of its blockbuster weight-loss treatment in the U.K. The Medicines and Healthcare Products Regulatory Agency approved a maximum dose of up to 7.2 milligrams per week of Wegovy, a step up from the previous 2.4 mg limit.
ImmunityBio surged 40% after spiking 31% in Thursday's session. The biotech company expects full-year revenue from its bladder cancer drug Anktiva to surge 700% year over year to $113 million. Earlier this week, Immunitybio said the Saudi Food and Drug Authority had approved Anktiva for the treatment of patients with non-small cell lung cancer.
State Street declined 6.1%. The bank posted lower revenue in the fourth quarter, despite achieving "record revenue" of nearly $3.7 billion. Net income fell to $747 million from $783 million last year. Earnings came in at $2.42 a share, below the $2.79 analysts had expected.
Regions Financial slid 2.6%. The parent company of Regions Bank parent reported net income of $534 million for the fourth quarter, flat over the prior year. Adjusted earnings of 57 cents a share missed the 61 cents Wall Street had forecast.
PNC Financial Services gained 3.8% after fourth-quarter earnings topped analysts' estimates, with the company citing loan growth and higher demand for its financial services.
J.B. Hunt Transport Services fell 1%. Fourth-quarter sales declined 2% as prices and volumes fell across different parts of the business. Shares may have gotten ahead of themselves -- a 50% rally over the past three months has left the stock trading at about 29 times expected earnings, up from about 20 times earnings before the run started.
Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com and George Glover at george.glover@dowjones.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 16, 2026 16:18 ET (21:18 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
